Patent · US Active

Human plasma kallikrein inhibitors

US11203574B2 · kind B2 · utility

5Cited by
8References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2020
Grant dateDec 21, 2021
Priority date—
Expiry dateMar 24, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.